Bristol Myers (NYSE: BMY) EVP reports equity award vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bristol Myers Squibb executive vice president and chief research officer Robert M. Plenge reported multiple equity-compensation events in company stock. On March 10, 2026, prior market share units and performance shares vested and were exercised into a total of 17,501 shares of common stock, with 4,535 shares withheld at $60.13 per share to cover taxes.
Plenge also received new long-term incentives: 17,959 market share units and 26,939 performance share units scheduled to run to 2029, subject to performance certification by the board. Following these transactions, he holds 21,528 shares directly, plus indirect interests of 3,026.38 shares through the BMS Savings and Investment Program and 200 shares in a family trust. All actions reflect compensation vesting, internal adjustments, and tax withholding, with no open-market purchases or sales reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
17,501 shares exercised/converted
Mixed
16 txns
Insider
Plenge Robert M
Role
EVP, Chief Research Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Market Share Units | 1,107 | $0.00 | -- |
| Exercise | Market Share Units | 2,342 | $0.00 | -- |
| Exercise | Performance Shares | 14,052 | $0.00 | -- |
| Grant/Award | Market Share Units | 17,959 | $0.00 | -- |
| Grant/Award | Performance Shares | 26,939 | $0.00 | -- |
| Exercise | Common Stock, $0.10 par value | 1,107 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 124 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 436 | $60.13 | $26K |
| Exercise | Common Stock, $0.10 par value | 2,342 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 253 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 927 | $60.13 | $56K |
| Exercise | Common Stock, $0.10 par value | 14,052 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 6,900 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 3,172 | $60.13 | $191K |
| holding | Common Stock, $0.10 par value | -- | -- | -- |
| holding | Common Stock, $0.10 par value | -- | -- | -- |
Holdings After Transaction:
Market Share Units — 0 shares (Direct);
Performance Shares — 0 shares (Direct);
Common Stock, $0.10 par value — 16,946 shares (Direct);
Common Stock, $0.10 par value — 3,026.38 shares (Indirect, BMS Savings and Investment Program)
Footnotes (1)
- Represents vesting of one-quarter market share units granted on March 10, 2022. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter market share units granted on March 10, 2023. Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Based on recent 401(k) plan statement. Shares held in a family trust, where reporting person is a beneficiary. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. Each performance share unit converted into one share of common stock upon distribution in the first quarter of 2026. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
FAQ
What did BMY executive Robert M. Plenge report in this Form 4?
Robert M. Plenge reported vesting and exercise of equity awards and new grants. Market share units and performance shares converted into common stock, with some shares withheld for taxes, and additional long-term incentive awards were granted that extend to 2029, subject to performance certification.
What new equity awards did Robert M. Plenge receive from Bristol Myers (BMY)?
He received 17,959 market share units and 26,939 performance share units as new grants. These derivative awards run to 2029 and will convert into common stock based on performance factors and board certification of results under the company’s long-term incentive plan.
Does this BMY Form 4 show open-market buying or selling by Robert M. Plenge?
The filing shows no open-market purchases or sales by Robert M. Plenge. Reported movements relate to vesting and exercise of equity awards, internal adjustments, and shares withheld to cover tax obligations associated with those compensation events.